[go: up one dir, main page]

NO984667L - Sykliske adhesjonsinhibitorer - Google Patents

Sykliske adhesjonsinhibitorer

Info

Publication number
NO984667L
NO984667L NO984667A NO984667A NO984667L NO 984667 L NO984667 L NO 984667L NO 984667 A NO984667 A NO 984667A NO 984667 A NO984667 A NO 984667A NO 984667 L NO984667 L NO 984667L
Authority
NO
Norway
Prior art keywords
adhesion inhibitors
cyclic adhesion
cyclic
inhibitors
adhesion
Prior art date
Application number
NO984667A
Other languages
English (en)
Norwegian (no)
Other versions
NO984667D0 (no
Inventor
Alfred Jonczyk
Simon Goodman
Beate Diefenbach
Horst Kessler
Marcus Koppitz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO984667D0 publication Critical patent/NO984667D0/no
Publication of NO984667L publication Critical patent/NO984667L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO984667A 1996-04-06 1998-10-06 Sykliske adhesjonsinhibitorer NO984667L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19613933A DE19613933A1 (de) 1996-04-06 1996-04-06 Cyclische Adhäsionsinhibitoren
PCT/EP1997/001657 WO1997038009A1 (de) 1996-04-06 1997-04-02 Cyclische adhäsionsinhibitoren

Publications (2)

Publication Number Publication Date
NO984667D0 NO984667D0 (no) 1998-10-06
NO984667L true NO984667L (no) 1998-10-06

Family

ID=7790744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984667A NO984667L (no) 1996-04-06 1998-10-06 Sykliske adhesjonsinhibitorer

Country Status (24)

Country Link
US (1) US6127335A (es)
EP (1) EP0904285B1 (es)
JP (1) JP4115530B2 (es)
KR (1) KR100438378B1 (es)
CN (1) CN1119351C (es)
AR (1) AR006523A1 (es)
AT (1) ATE224402T1 (es)
AU (1) AU717496B2 (es)
BR (1) BR9708530A (es)
CA (1) CA2250861C (es)
CZ (1) CZ291510B6 (es)
DE (2) DE19613933A1 (es)
DK (1) DK0904285T3 (es)
ES (1) ES2183159T3 (es)
HU (1) HUP9903631A3 (es)
NO (1) NO984667L (es)
PL (1) PL187924B1 (es)
PT (1) PT904285E (es)
RU (1) RU2184121C2 (es)
SK (1) SK283718B6 (es)
TW (1) TW570929B (es)
UA (1) UA61071C2 (es)
WO (1) WO1997038009A1 (es)
ZA (1) ZA972843B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
PL350291A1 (en) 1998-12-23 2002-12-02 Searle & Co Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6521593B1 (en) * 1999-02-01 2003-02-18 Childrens Hospital Los Angeles Methods for inhibiting brain tumor growth
UA71608C2 (en) 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
ATE415163T1 (de) 2000-11-01 2008-12-15 Merck Patent Gmbh Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
UA75898C2 (en) * 2000-11-14 2006-06-15 Merck Patent Gmbh Method for prophylaxis and treatment of eye diseases using antagonist of integrin receptors
JP4499327B2 (ja) * 2001-12-06 2010-07-07 松崎 浩巳 拡径器具および手術器具セット
EP1487489A4 (en) * 2002-03-04 2008-10-01 Medimmune Inc METHOD FOR PREVENTING OR TREATING ILLNESSES BY ADMINISTERING AN INTEGRIN AVB3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
EP1487492A4 (en) * 2002-03-04 2008-10-01 Medimmune Inc PREVENTION OR TREATMENT OF CANCER WITH INTEGRIN ALPHAVBETA3 ANTAGONISTS IN COMBINATION WITH OTHER MEDICINES
DK1483251T3 (da) 2002-03-12 2010-04-12 Bristol Myers Squibb Co C3-cyano-epothilon-derivater
ITRM20020402A1 (it) * 2002-07-29 2004-01-29 Sigma Tau Ind Farmaceuti Derivati fluoro-alchil-ciclopeptidi ad attivita' anti-integrine.
BR0313534A (pt) * 2002-08-16 2005-07-12 Janssen Pharmaceutica Nv Antagonistas de integrinade ácido carboxìlico de piperidinoìla
US20040224986A1 (en) 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
RU2234331C1 (ru) * 2002-12-30 2004-08-20 Смирнов Алексей Владимирович Лекарственное средство
WO2004066956A2 (en) * 2003-01-30 2004-08-12 Medimmune, Inc. Uses of integrin alphavbeta3 antagonists
JP5647972B2 (ja) * 2008-04-08 2015-01-07 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 環状ペプチドを含む組成物および使用方法
EP3392262B1 (en) * 2017-04-17 2021-08-18 National Tsing Hua University Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same
US10745444B2 (en) * 2017-04-17 2020-08-18 National Tsing Hua University Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same
US10494403B2 (en) 2018-03-06 2019-12-03 Ciphore Biomed Technology Limited Company Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ279654B6 (cs) * 1987-12-21 1995-05-17 Sandoz Ag Způsob výroby cyklosporinu A
CN1077279A (zh) * 1992-04-09 1993-10-13 北京矿冶研究总院 雷管桥丝发火电阻安全检测仪
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
WO1994018235A1 (fr) * 1993-02-04 1994-08-18 Banyu Pharmaceutical Co., Ltd. Nouveau pentapeptide cyclique
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE19534177A1 (de) * 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren

Also Published As

Publication number Publication date
ES2183159T3 (es) 2003-03-16
UA61071C2 (en) 2003-11-17
PL329154A1 (en) 1999-03-15
BR9708530A (pt) 1999-08-03
US6127335A (en) 2000-10-03
DE59708269D1 (de) 2002-10-24
DK0904285T3 (da) 2003-01-27
NO984667D0 (no) 1998-10-06
HUP9903631A2 (hu) 2000-03-28
SK283718B6 (sk) 2003-12-02
DE19613933A1 (de) 1997-10-09
PL187924B1 (pl) 2004-11-30
CN1119351C (zh) 2003-08-27
PT904285E (pt) 2003-02-28
KR20000005210A (ko) 2000-01-25
EP0904285A1 (de) 1999-03-31
CZ291510B6 (cs) 2003-03-12
EP0904285B1 (de) 2002-09-18
AU717496B2 (en) 2000-03-30
AR006523A1 (es) 1999-09-08
TW570929B (en) 2004-01-11
HUP9903631A3 (en) 2000-04-28
JP2000510102A (ja) 2000-08-08
CZ320398A3 (cs) 1999-01-13
RU2184121C2 (ru) 2002-06-27
CA2250861C (en) 2008-07-15
ZA972843B (en) 1998-02-19
ATE224402T1 (de) 2002-10-15
CA2250861A1 (en) 1997-10-16
WO1997038009A1 (de) 1997-10-16
SK136498A3 (en) 1999-05-07
KR100438378B1 (ko) 2004-08-25
AU2568897A (en) 1997-10-29
CN1218478A (zh) 1999-06-02
JP4115530B2 (ja) 2008-07-09

Similar Documents

Publication Publication Date Title
ATE189461T1 (de) Cyclische adhäsionsinhibitoren
DE69621026D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DE69637328D1 (de) Zelladhäsionsinhibitoren
FI973087L (fi) Soluadheesion inhibiittoreita
FI963597A7 (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
ATE249212T1 (de) Refluxinhibitoren
FI972160A0 (fi) Matriisimetalloproteaasi-inhibiittorit
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DK0904285T3 (da) Cykliske adhæsionsinhibitorer
DE59707990D1 (de) Adhäsive
PT956294E (pt) Inibidores da trombina
DE69709833D1 (de) Wellenformentzerrer
PT948483E (pt) Inibidores da farnesil-transferase
ATE282629T1 (de) Thrombininhibitoren
DE69720957T2 (de) Ace-hemmer
BR9610514A (pt) Inibidores cicloantihelmínticos
SI0904285T1 (en) Cyclic adhesion inhibitors
KR970049480U (ko) 접착테이프용 첩부기
CY2007006I2 (el) Αναστολεις συνθεσεις απολιποπρωτεϊνης-β

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application